• 专利标题:   Label-free detection of thrombin in to-be-detected sample e.g. saliva, involves adding to-be-detected sample to system of oxidized graphene, perylene derivative as probe, thrombin nucleic acid aptamer, solvent and buffer solution, and detecting fluorescence intensity to detect thrombin concentration.
  • 专利号:   CN115436335-A
  • 发明人:   LIU J, DUAN X, QIAN S, WANG M, DING Y, BAI Q, YE M, ZHANG N, WANG F
  • 专利权人:   UNIV ZUNYI MEDICAL
  • 国际专利分类:   G01N021/64
  • 专利详细信息:   CN115436335-A 06 Dec 2022 G01N-021/64 202312 Chinese
  • 申请详细信息:   CN115436335-A CN11127405 16 Sep 2022
  • 优先权号:   CN11127405

▎ 摘  要

NOVELTY - Label-free detection of thrombin based on perylene derivative probe involves adding a to-be-detected sample to a detection system comprising oxidized graphene, perylene derivative (I) as a probe, a thrombin nucleic acid aptamer, a solvent and a buffer solution, detecting fluorescence intensity with a fluorescence spectrometer, and measuring the thrombin concentration through the fluorescence intensity. USE - Label-free detection of thrombin in to-be-detected sample e.g. aqueous solution, serum, saliva or cell lysate (all claimed). ADVANTAGE - The method enables simple, convenient, efficient and rapid label-free detection of thrombin in to-be-detected sample using economical materials under non-toxic, mild reaction conditions, with good selectivity, good stability and high sensitivity, and without requiring complex procedures and large instruments. In the label-free detection of thrombin, good linear response is in the range of 6 mU/mL, and the detection limit is as low as 0.082 mU/mL. The method solves the existing problems of needing fluorescent labels, poor stability, cumbersome steps, and high cost. DETAILED DESCRIPTION - Label-free detection of thrombin based on perylene derivative probe involves adding a to-be-detected sample to a detection system comprising oxidized graphene, perylene derivative of formula (I) as a probe, a thrombin nucleic acid aptamer, a solvent and a buffer solution, detecting fluorescence intensity with a fluorescence spectrometer, and measuring the thrombin concentration through the fluorescence intensity.